Biogen BIIB
NASDAQ BIIB
$215.45 +4.72 (+2.24%)
As of: Sep 10, 2026 · 3:59 PM EDT

Biogen (BIIB) Intangibles (2009 - 2026)

Biogen (BIIB) posted Intangibles of $13.5 billion for Q2 2026, up 49.29% on a QoQ basis from $9.1 billion in Q1 2026, and up 42.77% year-over-year from $9.5 billion in Q2 2025.

Analysis

Biogen (BIIB) Intangibles (2009 - 2026) Analysis & Trends

Biogen has reported Intangibles for 18 years, with the latest figure at $13.5 billion in Q2 2026.

  • On a quarterly basis, Intangibles rose 42.77% year-over-year to $13.5 billion in Q2 2026; TTM through Jun 2026 was $13.5 billion, a 42.77% increase from a year earlier, with the FY2025 full-year figure at $9.2 billion, down 5.29% from the prior year.
  • Intangibles was $13.5 billion for Q2 2026 at Biogen, up from $9.1 billion in the prior quarter.
  • The five-year high for Intangibles was $13.5 billion in Q2 2026, with the low at $1.8 billion in Q2 2023.
  • Average Intangibles over 5 years is $6.9 billion, with a median of $8.3 billion recorded in 2024.
  • The sharpest annual moves came in 2022 and 2024: Intangibles decreased 28.02% in 2022, then soared 363.46% in 2024.
  • Over 5 years, Intangibles stood at $1.9 billion in 2022, then soared by 352.03% to $8.4 billion in 2023, then gained by 15.88% to $9.7 billion in 2024, then retreated by 5.29% to $9.2 billion in 2025, then jumped by 47.26% to $13.5 billion in 2026.
  • The last three Intangibles figures came in at $13.5 billion (Q2 2026), $9.1 billion (Q1 2026), and $9.2 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 20.49 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 14.03 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 412.80 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 1.31 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 266.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 13.52 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Insmed 27.67 Bn 26.51 Bn 358.27 Mn 93.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.52 Bn
Mar 31, 2026 9.05 Bn
Dec 31, 2025 9.18 Bn
Sep 30, 2025 9.33 Bn
Jun 30, 2025 9.47 Bn
Mar 31, 2025 9.58 Bn
Dec 31, 2024 9.69 Bn
Sep 30, 2024 9.81 Bn
Jun 30, 2024 8.23 Bn
Mar 31, 2024 8.28 Bn
Dec 31, 2023 8.36 Bn
Sep 30, 2023 7.34 Bn
Jun 30, 2023 1.78 Bn
Mar 31, 2023 1.81 Bn
Dec 31, 2022 1.85 Bn
Sep 30, 2022 2.01 Bn
Jun 30, 2022 2.08 Bn
Mar 31, 2022 2.15 Bn
Dec 31, 2021 2.22 Bn
Sep 30, 2021 2.29 Bn